scholarly journals Vascular Endothelial Growth Factor (VEGF) Expression in Oral Cancer and its Correlation with Clinico-Pathological Parameters- A Prospective Study

2019 ◽  
Vol 8 (31) ◽  
pp. 2462-2466
Author(s):  
Ashish Singhal ◽  
Rahat Hadi ◽  
Charu Mahajan ◽  
Nuzhat Husain
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Oral Cancer ◽  
Prospective Study ◽  
Vascular Endothelial ◽  
Vegf Expression ◽  
A Prospective Study ◽  
Endothelial Growth Factor

scholarly journals Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study

2001 ◽  
Vol 233 (2) ◽  
pp. 227-235 ◽  
Author(s):  
Ronnie Tung-Ping Poon ◽  
Irene Oi-Lin Ng ◽  
Cecilia Lau ◽  
Li-Xin Zhu ◽  
Wan-Ching Yu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Prospective Study ◽  
Venous Invasion ◽  
Vascular Endothelial ◽  
A Prospective Study ◽  
Endothelial Growth Factor

scholarly journals Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study

2012 ◽  
Vol 36 (11) ◽  
pp. 2315-2321 ◽  
Author(s):  
Shishir Rastogi ◽  
Ramakant Kumar ◽  
Sukesh Rao Sankineani ◽  
Kanniraj Marimuthu ◽  
Laxman Rijal ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Prospective Study ◽  
Tumour Marker ◽  
Vascular Endothelial ◽  
A Prospective Study ◽  
Endothelial Growth Factor

Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases

2007 ◽  
Vol 38 (10) ◽  
pp. 1489-1495 ◽  
Author(s):  
Nathalie Rioux-Leclercq ◽  
Patricia Fergelot ◽  
Salim Zerrouki ◽  
Emmanuelle Leray ◽  
Florence Jouan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Plasma Level ◽  
Prospective Study ◽  
Renal Cell ◽  
Tissue Expression ◽  
Vascular Endothelial ◽  
A Prospective Study ◽  
Endothelial Growth Factor

Evaluation of carboxymethylcellulose sodium + glycerin, (Optive®) in ocular discomfort after anti-vascular endothelial growth factor intravitreal injection therapy: a prospective study

2020 ◽  
Author(s):  
Mickael Karcenty ◽  
Camille Jung ◽  
Eric H. Souied ◽  
Celine Delacour ◽  
Alexandra Miere ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Prospective Study ◽  
Intravitreal Injection ◽  
Injection Therapy ◽  
Vascular Endothelial ◽  
Artificial Tear ◽  
Ocular Discomfort ◽  
A Prospective Study ◽  
Endothelial Growth Factor

Abstract Objective: To evaluate the efficacy of a mix of carboxymethylcellulose and glycerin (Optive®) after intra-vitreal injection therapy (IVT) with anti-vascular endothelial growth factor for reducing ocular discomfort in patients. Methods: We prospectively included patients who were naïve of any IVT. No artificial tear treatment was prescribed after the first IVT. After the second IVT, all patients instilled three drops per day of Optive® for 3 days. Every patient answered a questionnaire concerning the ocular discomfort at 72 hr after both IVTs and a questionnaire about tolerance to treatment after the second IVT. Results: We included 45 patients (mean age 72.3 years [range 23-94], 25 females); 14 (34.1%) reported a feeling of grittiness after the first IVT but not after the second (p = 0.01); 12 (29.3%) complained of global discomfort after the first IVT but not after the second (p = 0.14); and 11 (26.8%) reported a watery eye after the first IVT but not after the second (p = 0.21), for 37/45 (82%) patients feeling ocular discomfort after IVT. Conclusion: Most patients felt ocular discomfort after IVT. Instillation of Optive® significantly alleviated the feeling of grittiness for more than half of the patients.

Sign in / Sign up

Export Citation Format

Share Document